Rankings
▼
Calendar
HRMY Q4 2019 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena
HRMY
Harmony Biosciences Holdings, Inc.
$2B
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6M
Gross Profit
$4M
73.7% margin
Operating Income
-$34M
-562.0% margin
Net Income
-$36M
-607.8% margin
EPS (Diluted)
$-0.85
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$24M
Free Cash Flow
-$24M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$107M
Total Liabilities
$118M
Stockholders' Equity
-$12M
Cash & Equivalents
$24M
← FY 2019
All Quarters
Q1 2020 →
